Benitec Biopharma Ltd. Daily Stock Analysis

Daily Stock Analysis, BNTC, Benitec Biopharma Ltd, priceseries

Benitec Biopharma Ltd. Daily Stock Analysis
Stock Information
Open
2.25
Close
1.96
High
2.25
Low
1.91
Previous Close
2.21
Daily Price Gain
-0.25
YTD High
3.05
YTD High Date
Feb 10, 2022
YTD Low
1.91
YTD Low Date
Mar 7, 2022
YTD Price Change
-0.78
YTD Gain
-28.47%
52 Week High
10.49
52 Week High Date
Mar 23, 2021
52 Week Low
1.91
52 Week Low Date
Mar 7, 2022
52 Week Price Change
-0.83
52 Week Gain
-29.75%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 13. 2017
27.20
Jan 23. 2017
29.06
5 Trading Days
6.82%
Link
LONG
Mar 29. 2017
39.11
Apr 6. 2017
43.19
6 Trading Days
10.44%
Link
LONG
Oct 2. 2017
31.91
Oct 6. 2017
35.96
4 Trading Days
12.70%
Link
LONG
Oct 11. 2017
36.17
Oct 13. 2017
39.04
2 Trading Days
7.93%
Link
LONG
Oct 17. 2017
40.73
Oct 18. 2017
43.67
1 Trading Days
7.22%
Link
LONG
Jan 3. 2018
44.11
Jan 22. 2018
52.15
12 Trading Days
18.23%
Link
LONG
Jul 3. 2018
32.55
Jul 16. 2018
42.77
8 Trading Days
31.41%
Link
LONG
Feb 22. 2019
24.75
Mar 13. 2019
29.27
12 Trading Days
18.26%
Link
LONG
Jul 31. 2019
12.75
Aug 1. 2019
14.48
1 Trading Days
13.53%
Link
LONG
Dec 30. 2019
7.00
Jan 2. 2020
7.51
2 Trading Days
7.28%
Link
LONG
Feb 5. 2020
7.69
Feb 10. 2020
8.56
3 Trading Days
11.26%
Link
LONG
Apr 20. 2020
13.06
Apr 22. 2020
13.99
2 Trading Days
7.12%
Link
LONG
Jan 19. 2021
3.63
Jan 29. 2021
4.03
8 Trading Days
10.92%
Link
Company Information
Stock Symbol
BNTC
Exchange
NasdaqCM
Company URL
http://www.benitec.com
Company Phone
-
CEO
Gregory C. West
Headquarters
-
Business Address
-
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
-
About

Benitec Biopharma Ltd. engages in the development of therapeutics based on patented gene-silencing technology called ddRNAi or RNAi. It operates through the Australia and United States of America geographical segments. The company was founded by Kenneth C. Reed in 1997 and is headquartered in Melbourne, Australia.

Description

Developing gene therapies for hepatitis C based on RNA interference.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading